These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 3552595)

  • 1. Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Clissold SP; Todd PA; Campoli-Richards DM
    Drugs; 1987 Mar; 33(3):183-241. PubMed ID: 3552595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thienamycin: development of imipenen-cilastatin.
    Kahan FM; Kropp H; Sundelof JG; Birnbaum J
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():1-35. PubMed ID: 6365872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
    Pastel DA
    Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin.
    Birnbaum J; Kahan FM; Kropp H; MacDonald JS
    Am J Med; 1985 Jun; 78(6A):3-21. PubMed ID: 3859213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Imipenem/cilastatin: in vitro activity, concentrations in plasma and prostatic adenoma and therapeutic results in patients with complicated urinary tract infections].
    Naber KG; Adam D; Bauernfeind A; Hönig E
    Infection; 1986; 14 Suppl 2():S122-9. PubMed ID: 2428754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profile of imipenem/cilastatin in normal volunteers.
    Drusano GL; Standiford HC
    Am J Med; 1985 Jun; 78(6A):47-53. PubMed ID: 3859215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS; Pressler T; Jensen T; Rosdahl VT; Bentzon MW; Høiby N; Koch C
    J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipenem/cilastatin.
    Barza M
    Eur J Clin Microbiol; 1984 Oct; 3(5):453-5. PubMed ID: 6594233
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fundamental and clinical studies on imipenem/cilastatin sodium in the field of pediatrics].
    Nakashima T; Nakashima S; Hayakawa F; Miyachi Y; Hakamada S; Kuno K
    Jpn J Antibiot; 1986 Jul; 39(7):1828-46. PubMed ID: 3464781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipenem-cilastatin: the first thienamycin antibiotic.
    Jacobs RF
    Pediatr Infect Dis; 1986; 5(4):444-8. PubMed ID: 3523460
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of imipenem and cilastatin in volunteers.
    Rogers JD; Meisinger MA; Ferber F; Calandra GB; Demetriades JL; Bland JA
    Rev Infect Dis; 1985; 7 Suppl 3():S435-46. PubMed ID: 3863219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Buckley MM; Brogden RN; Barradell LB; Goa KL
    Drugs; 1992 Sep; 44(3):408-44. PubMed ID: 1382937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New antimicrobial agent series XXV: imipenem/cilastatin sodium].
    Mashimo K
    Jpn J Antibiot; 1987 Oct; 40(10):1713-23. PubMed ID: 3327961
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics].
    Bompard Y; Lambert T; Gantzer A; Chastel A; Voinnesson A; Aufrant C
    Pathol Biol (Paris); 1988 May; 36(5):521-4. PubMed ID: 3043351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
    Calandra GB; Hesney M; Grad C
    Eur J Clin Microbiol; 1984 Oct; 3(5):478-87. PubMed ID: 6389126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic and clinical studies with imipenem/cilastatin sodium in the pediatric field. Pediatric Study Group for Imipenem/Cilastatin Sodium].
    Fujii R; Meguro H; Arimasu O; Yoshioka H; Fujita K; Maruyama S; Inyaku F; Nagamatsu I; Wagatsuma Y; Takase A
    Jpn J Antibiot; 1986 Jul; 39(7):1912-37. PubMed ID: 3464785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative clinical trial of imipenem-cilastatin (N-formimidoyl-thienamycin-dehydropeptidase inhibitor) and cefazolin.
    Marier RL; McCloskey RV; Dickenson G; Sanders CV; Aldridge KE; Hoffman T; Gutterman D; Janney A
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():133-9. PubMed ID: 6365873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of gram-negative bacillary meningitis with imipenem/cilastatin.
    Rodriguez K; Dickinson GM; Greenman RL
    South Med J; 1985 Jun; 78(6):731-2. PubMed ID: 3859018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis.
    Reed MD; Stern RC; O'Brien CA; Yamashita TS; Myers CM; Blumer JL
    Antimicrob Agents Chemother; 1985 Apr; 27(4):583-8. PubMed ID: 3859245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.